These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 36593435)

  • 1. Rotenone-Induced Model of Parkinson's Disease: Beyond Mitochondrial Complex I Inhibition.
    Ibarra-Gutiérrez MT; Serrano-García N; Orozco-Ibarra M
    Mol Neurobiol; 2023 Apr; 60(4):1929-1948. PubMed ID: 36593435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Mitochondrial Toxin Rodent Models of Parkinson's Disease Using 6-OHDA , MPTP , and Rotenone.
    Maegawa H; Niwa H
    Methods Mol Biol; 2021; 2322():95-110. PubMed ID: 34043196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine.
    Santiago RM; Barbieiro J; Lima MM; Dombrowski PA; Andreatini R; Vital MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1104-14. PubMed ID: 20547199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD).
    Schmidt WJ; Alam M
    J Neural Transm Suppl; 2006; (70):273-6. PubMed ID: 17017541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.
    Bazzu G; Calia G; Puggioni G; Spissu Y; Rocchitta G; Debetto P; Grigoletto J; Zusso M; Migheli R; Serra PA; Desole MS; Miele E
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):482-90. PubMed ID: 20522009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of Parkinson's disease in rodents induced by toxins: an update.
    Hirsch EC; Höglinger G; Rousselet E; Breidert T; Parain K; Feger J; Ruberg M; Prigent A; Cohen-Salmon C; Launay JM
    J Neural Transm Suppl; 2003; (65):89-100. PubMed ID: 12946051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Richardson JR; Caudle WM; Guillot TS; Watson JL; Nakamaru-Ogiso E; Seo BB; Sherer TB; Greenamyre JT; Yagi T; Matsuno-Yagi A; Miller GW
    Toxicol Sci; 2007 Jan; 95(1):196-204. PubMed ID: 17038483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
    Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
    Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.
    Schober A
    Cell Tissue Res; 2004 Oct; 318(1):215-24. PubMed ID: 15503155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Rotenone to Model Parkinson's Disease in Mice: A Review of the Role of Pharmacokinetics.
    Innos J; Hickey MA
    Chem Res Toxicol; 2021 May; 34(5):1223-1239. PubMed ID: 33961406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of caloric vestibular stimulation in improvement of motor symptoms and inhibition of neuronal degeneration in rotenone model of Parkinson's disease - An experimental study.
    Thanalakshmi J; Archana R; Senthilkumar S; Shakila R; Pazhanivel N; Subhashini S
    Physiol Int; 2020 Oct; 107(3):390-405. PubMed ID: 33021954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxin-induced models of Parkinson's disease.
    Bové J; Prou D; Perier C; Przedborski S
    NeuroRx; 2005 Jul; 2(3):484-94. PubMed ID: 16389312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model.
    Gu PS; Moon M; Choi JG; Oh MS
    J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.
    Tapias V; Cannon JR; Greenamyre JT
    J Neurosci Res; 2010 Feb; 88(2):420-7. PubMed ID: 19681169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain activation and progression of inflammatory cycles in Parkinson's disease.
    Gao A; McCoy HM; Zaman V; Shields DC; Banik NL; Haque A
    Front Biosci (Landmark Ed); 2022 Jan; 27(1):20. PubMed ID: 35090325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease.
    Miyazaki I; Isooka N; Imafuku F; Sun J; Kikuoka R; Furukawa C; Asanuma M
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotoxin-based models of Parkinson's disease.
    Bové J; Perier C
    Neuroscience; 2012 Jun; 211():51-76. PubMed ID: 22108613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease.
    Corona JC; Gimenez-Cassina A; Lim F; Díaz-Nido J
    J Neurosci Res; 2010 Jul; 88(9):1943-50. PubMed ID: 20143419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease, lights and melanocytes: looking beyond the retina.
    Willis GL; Moore C; Armstrong SM
    Sci Rep; 2014 Jan; 4():3921. PubMed ID: 24473093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.
    Duty S; Jenner P
    Br J Pharmacol; 2011 Oct; 164(4):1357-91. PubMed ID: 21486284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.